Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 2023 12 Oktober 2023NewsVeterinaryMedicines Monitoring of products originating from Japan for the possibility of radioactivity 11 Oktober 2023News Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 2023 6 Oktober 2023NewsVeterinaryMedicines EMA Management Board: highlights of October 2023 meeting 6 Oktober 2023NewsCorporate Revised transparency rules for the EU Clinical Trials Information System (CTIS) 6 Oktober 2023News EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 Oktober 2023NewsHumanMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 September 2023NewsHumanPharmacovigilanceReferrals EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 September 2023NewsHumanMedicines Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 September 2023NewsHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 September 2023NewsHumanCOVID-19MedicinesReferrals 1 … 27 28 29 30 31 Page 31 of 385 32 33 34 35 … 385
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 2023 12 Oktober 2023NewsVeterinaryMedicines
Monitoring of products originating from Japan for the possibility of radioactivity 11 Oktober 2023News
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 2023 6 Oktober 2023NewsVeterinaryMedicines
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 Oktober 2023NewsHumanMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 September 2023NewsHumanPharmacovigilanceReferrals
EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 September 2023NewsHumanMedicines
Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 September 2023NewsHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 September 2023NewsHumanCOVID-19MedicinesReferrals